STREAMEX CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value
STREAMEX CORP. (STEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value of $244770.00 per share for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue · last filed 2023-08-14
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for the quarter ending 2023-03-31 was $184520.00.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for the quarter ending 2021-03-31 was $308891.00, a 20.60% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for the quarter ending 2020-03-31 was $389031.00, a 90.65% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for the quarter ending 2019-03-31 was $4162880.00.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for fiscal 2020 was $110961.00, a 96.46% decline from fiscal 2019.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for fiscal 2019 was $3130791.00.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for fiscal 2018 was $0.00.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, grants in period, grant date intrinsic value for fiscal 2017 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-06-30 | $244770.00 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | $184520.00 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | $3000.00 10-Q · filed 2023-08-14 | |||||
| 2021-09-30 | $938.00 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $190635.00 10-Q · filed 2021-08-11 | |||||
| 2021-03-31 | $308891.00 10-Q · filed 2021-05-17 | |||||
| 2020-12-31 | $110961.00 10-K · filed 2023-03-31 | $110961.00 10-K · filed 2022-03-31 | ||||
| 2020-03-31 | $389031.00 10-Q · filed 2020-05-11 | |||||
| 2020-01-01 | $3130791.00 10-K · filed 2022-03-31 | |||||
| 2019-12-31 | $3130791.00 10-Q · filed 2020-05-11 | $3130791.00 10-K · filed 2021-03-15 | ||||
| 2019-03-31 | $4162880.00 10-Q · filed 2019-04-15 | |||||
| 2019-01-01 | $0.00 10-K · filed 2021-03-15 | |||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-13 | $311545.00 10-K · filed 2019-03-15 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-13 | $0.00 10-K · filed 2019-03-15 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-15 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-28 | |||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |